Morepen Laboratories Performance
Day's Low
Day's High
₹67.07Day's Price Range₹68.452 Week's Low
52 Week's High
₹38.5552-Week Price Range₹100.9
| Returns % | |
| 1 Month Return | -19.8 % |
| 3 Month Return | -21.18 % |
| 1 Year Return | + 43.49 % |
| Market Stats | |
| Previous Close | ₹68.14 |
| Open | ₹68.20 |
| Volume | 32.09L |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹3,733.76Cr |
Morepen Laboratories Key Statistics
| P/E Ratio | 26.66 |
| PEG Ratio | 17.65 |
| Market Cap | ₹3,733.76 Cr |
| P/B Ratio | 2.42 |
| EPS | 1.89 |
| Dividend Yield | 0 |
| Sector | Pharmaceuticals |
| ROE | 13.29 |
Morepen Laboratories Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| NA | ₹3,733.76 Cr | 67.02% | 0.53 | ₹96 Cr | ₹1,690 Cr | |
| NA | ₹10.17 Cr | 94.34% | 0.88 | NA | NA | |
| NA | ₹261.26 Cr | 97.58% | 0.52 | ₹16 Cr | ₹108 Cr | |
| NA | ₹122.53 Cr | 40.58% | 0.51 | NA | NA | |
| NA | ₹14,909.73 Cr | -1.26% | 0.73 | ₹82 Cr | ₹1,465 Cr |
About Morepen Laboratories
Share Price: ₹67.44 per share as on 17 Jan, 2025 04:01 PM
Market Capitalisation: ₹3,733.76Cr as of today
Revenue: ₹437.73Cr as on September 2024 (Q3 24)
Net Profit: ₹34.85Cr as on September 2024 (Q3 24)
Listing date: 15 May, 1995
Chairperson Name: Sushil Suri
| Organisation | Morepen Laboratories |
| Headquarters | Gurgaon |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
Key events for Morepen Laboratories Ltd
Morepen Laboratories Hives Off Medical Devices Business - 14 Jan, 2025
Morepen Laboratories has approved the transfer of its medical devices business to a newly formed subsidiary, Morepen Medtech, on a slump sale basis. The transaction requires regulatory and shareholder approvals and aims to enhance operational focus in the medical devices segment. Completion is expected by September 30, 2025.Morepen Laboratories Stock Declines Significantly - 06 Jan, 2025
On January 6, 2025, Morepen Laboratories' stock fell by 7.58%, underperforming its sector. Despite a strong YoY profit growth, the stock remains cautious.Morepen Laboratories Establishes New Medical Devices Subsidiary - 27 Dec, 2024
Morepen Laboratories Limited has announced the formation of a new subsidiary focused on medical devices, acquiring an 80% stake to enhance its business operations and strategic goals.
Insights on Morepen Laboratories Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRetail Holding Up
Retail Investor have increased holdings from 53.72% to 60.56% in Sep 2024 quarter
NO EFFECTAgainst Peers
In the last 1 year, Divis Laboratories Ltd has given 46.6% return, outperforming this stock by 12.5%
- NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 35.65% of holdings in Sep 2024 quarter
- NO EFFECT
Against Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 103.2% return, outperforming this stock by 84.4%
NEGATIVE IMPACTProfit Down
Netprofit is down for the last 2 quarters, 36.17 Cr → 34.85 Cr (in ₹), with an average decrease of 3.7% per quarter
- NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 458.64 Cr → 442.71 Cr (in ₹), with an average decrease of 3.5% per quarter
- NEGATIVE IMPACT
FII Holding Down
Foreign Institutions have decreased holdings from 7.72% to 2.08% in Sep 2024 quarter
- NEGATIVE IMPACT
Price Dip
In the last 7 days, MOREPENLAB stock has moved down by -14.0%
Morepen Laboratories Financials
Index Inclusions
Morepen Laboratories Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 35.65% | 0.00 | |
| Foreign Institutions | 2.08% | ||
| Mutual Funds | 0% | 157.14 | |
| Retail Investors | 60.56% | 12.74 | |
| Others | 1.71% |
Morepen Laboratories Key Indicators
Morepen Laboratories Valuation
Morepen Laboratories in the last 5 years
Lowest (10.48x)
March 23, 2020
Today (26.66x)
January 17, 2025
Industry (54.95x)
January 17, 2025
Highest (64.70x)
January 22, 2018
Morepen Laboratories Earnings and Dividends
Morepen Laboratories Ltd Earnings Results
Morepen Laboratories Ltd’s net profit jumped 63.92% since last year same period to ₹34.85Cr in the Q2 2024-2025. On a quarterly growth basis, Morepen Laboratories Ltd has generated -3.65% fall in its net profits since last 3-months.
Read More about Earnings Results
Morepen Laboratories Technicals Summary
Bearish
Neutral
Bullish
Morepen Laboratories Ltd is currently in a Bearish trading position according to technical analysis indicators.
FAQs on Morepen Laboratories Ltd
Morepen Laboratories Ltd share price today stands at ₹67.44, Open. ₹68.2 ; Previous Close. ₹68.14 ; High. ₹68.4 ; Low. ₹67.07 ; 52 Week High. ₹100.9 ; 52 Week Low: ₹38.55.
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Morepen Laboratories Ltd shares.
Morepen Laboratories Ltd is listed on NSE
Morepen Laboratories Ltd is listed on BSE
- Today’s highest price of Morepen Laboratories Ltd is ₹68.4.
- Today’s lowest price of Morepen Laboratories Ltd is ₹67.07.
PE Ratio of Morepen Laboratories Ltd is 26.66
PE ratio = Morepen Laboratories Ltd Market price per share / Morepen Laboratories Ltd Earnings per share
Today’s traded volume of Morepen Laboratories Ltd(MOREPENLAB) is 32.09L.
Today’s market capitalisation of Morepen Laboratories Ltd(MOREPENLAB) is ₹3733.76Cr.
| Morepen Laboratories Ltd(MOREPENLAB | Price |
|---|---|
52 Week High | ₹100.9 |
52 Week Low | ₹38.55 |
Morepen Laboratories Ltd(MOREPENLAB) share price is ₹67.44. It is down -33.16% from its 52 Week High price of ₹100.9
Morepen Laboratories Ltd(MOREPENLAB) share price is ₹67.44. It is up 74.94% from its 52 Week Low price of ₹38.55
| Morepen Laboratories Ltd(MOREPENLAB | Returns |
|---|---|
1 Day Returns | -0.7% |
1 Month Returns | -19.8% |
3 Month Returns | -21.18% |
1 Year Returns | 43.49% |